| Literature DB >> 27837775 |
Kristina B Martinez1, Joseph F Pierre1, Eugene B Chang2.
Abstract
Obesity is an emerging global epidemic with profound challenges to world health care economies and societies. Traditional approaches to fighting obesity have not shown promise in promoting a decline in obesity prevalence. The gut microbiota is becoming widely appreciated for its role in regulating metabolism and thus represents a target for new therapies to combat obesity and associated comorbidities. This article provides an overview of altered microbial community structure in obesity, dietary impact on the gut microbiota, host-microbe interactions contributing to the disease, and improvements in microbial assemblage after bariatric surgery and with therapies targeting the gut microbiome.Entities:
Keywords: Bariatric surgery; Enteroendocrine hormones; Lipid absorption; Metabolism; Microbiota; Prebiotics; Probiotics; Synbiotics
Mesh:
Substances:
Year: 2016 PMID: 27837775 PMCID: PMC5127273 DOI: 10.1016/j.gtc.2016.07.001
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806